Entries by Caroline

NMIBC treatment update: medac plans stable production of BCG-medac in the medium term

10 March, 2023 in /by

  Wedel, Germany (2023-03-10) Over the course of 2023 and 2024, medac GmbH plans to be in a position to successively supply all markets with an existing BCG-medac marketing authorisation and currently inactive marketing status with the immunotherapy product for the treatment of non-muscle invasive bladder cancer (NMIBC). This step has been made possible through […]

Nordic grant for research or projects focusing on stem cell transplantation

1 February, 2023 in /by

medac announces a Nordic grant for research or projects focusing on stem cell transplantation to support Nordic resident physicians and specialists within hematology. Clinical projects within allogenic or autologous stem cell transplantation are eligible. Research/projects involving one or more of the Nordic countries will be prioritized. Applications should be submitted before September 1st, 2023, to […]